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Mutations of the RET-GDNF Signaling Pathway in
Ondine’s Curse
To the Editor:
The congenital central hypoventilation syndrome
(CCHS, or Ondine’s curse; MIM 209880; McKusick
1997) is a hitherto unexplained disorder of the venti-
latory response to hypoxia and hypercapnia, leading to
life-threatening hypoxic episodes starting immediatly af-
ter birth (Mellins et al. 1970). The alveolar hypoventi-
lation observed during sleep is regarded as the conse-
quence of a failure of the autonomic control of
ventilation, located in the ventral medulla of the brain
stem. Although the majority of CCHS cases are sporadic,
several familial forms have been reported, and segre-
gation analyses have suggested that the multifactorial
and the major-locus models are almost equally likely in
CCHS (Weese-Mayer et al. 1993). Interestingly, the
CCHS-Hirschsprung disease association has frequently
been reported (Haddad syndrome; MIM 209880
[McKusick 1997]; Haddad et al. 1978; Nakahara et al.
1995), and all CCHS families reported, to date, have
included at least one sibling with this association.
On the other hand, Hirschsprung disease (HSCR;
aganglionic megacolon; MIM 249200; McKusick 1997)
is a frequent congenital malformation (1/5,000 live
births) that is characterized by the absence of parasym-
pathetic intrinsic ganglion cells of the hindgut and is
regarded as a neurocristopathy (Bolande 1973). RET
mutations account for 50% and 15%–20% of isolated
familial and sporadic HSCR, respectively (Attie´ et al.
1995a). Mutations in the endothelin signaling pathway,
including the endothelin B receptor gene (EDNRB) and
the endothelin 3 gene (EDN3), account for no more than
5% of HSCR cases (Puffenberger et al. 1994; Attie´ et
al. 1995b; Amiel et al. 1996; Ede´ry et al. 1996). Since
CCHS is also regarded as the consequence of an ab-
normal migration of the neural crest cells toward the
central autonomic respiratory system, genes involved in
HSCR were considered as candidate genes in CCHS as
well, including the RET proto-oncogene and its ligand,
the glial cell line–derived neurotrophic factor (GDNF;
Durbec et al. 1996; Salomon et al. 1996), EDNRB, and
EDN3.
Although a heterozygous EDN3 frameshift mutation
has been found in one CCHS patient (Bolk et al. 1996b),
we failed to detect EDNRB or EDN3 mutations in our
series. By contrast, screening the coding sequence of the
RET and GDNF genes in five unrelated cases of isolated
CCHS and in two cases of CCHS-HSCR association, we
found mutations of the RET and the GDNF genes in
children with isolated CCHS (1/7) and the CCHS-HSCR
association (1/7), respectively.
All patients fulfilled the inclusion criteria for diagnosis
of CCHS, namely (i) hypoventilation, hypoxemia, and
hypercapnia during quiet sleep on polygraphic respira-
tory recording, with (ii) no cardiac, pulmonary, neuro-
muscular, electroencephalographic or cerebral magnetic
resonance imaging anomaly. Histopathological criteria
for HSCR were (i) the absence of enteric plexuses with
histological evaluation of the aganglionic tract and (ii)
increased acetylcholinesterase histochemical staining in
nerve fibers. We screened RET and GDNF genes by
SSCP analysis (Attie´ et al. 1995a; Salomon et al. 1996).
The PCR products were heated for 10 min at 95C,
loaded onto a Hydrolink mutation detection enhance-
ment gel (Bioprobe), and electrophoresed at 4 W. The
gel was then dried and autoradiographed for 48 h. When
an abnormal SSCP pattern was observed, direct DNA
sequencing was performed by the fluorometric method
(DyeDeoxyTerminator cycle sequencing kit, Applied
Biosystems).
In a female patient with CCHS and total colonic agan-
glionosis, we found a hitherto unreported CrT transi-
tion at the second nucleotide of codon 1039 in exon 19
of the RET gene (CCGrCTG), changing a proline into
a leucine in the protein (P1039L; fig. 1). This mutation
is located in the terminal end of the intracellular domain
of RET and is predicted to alter both the long and short
carboxy-terminal isoforms of the RET protein. The mu-
tation was inherited from the healthy father, and no
other deleterious variation in RET coding sequence was
detected (the A432A and G691S polymorphisms were
noted in exons 7 and 11, respectively). In a male patient
with CCHS and growth hormone deficiency, we found
a CrT transition at the first nucleotide of codon 93 of
the GDNF gene (CGGrTGG), changing a highly con-
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Figure 1 SSCP analysis of RET exon 19 in case 1. F  father;
M  mother; P  proband; and C  control.
Figure 2 Screening for the R93W mutation by HinfI restriction
analysis. The nucleotide change abolishes the HinfI restriction site.
Partial digestion is found in the proband (case 2) and his mother (M),
showing heterozygosity for the R93W mutation, whereas complete
digestion is found in the father (F) and the control (C). D  digested
DNA; ND  nondigested DNA.
served arginine into a tryptophan in the protein (R93W;
fig. 2). This mutation was inherited from the healthy
mother. No other deleterious variation in the GDNF
coding sequence was detected. The two mutations were
absent in 90 normal controls (180 chromosomes). The
R93W mutation in the GDNF gene has already been
reported in sporadic and familial HSCR (Angrist et al.
1996; Salomon et al. 1996). In the latter case, since a
RET mutation was associated to the GDNF mutation,
the R93W mutation was regarded as neither necessary
nor sufficient to cause isolated HSCR. The lack of pen-
etrance of both RET and GDNF mutations reported
here suggests that a major secondary event, yet to be
defined, or the involvement of modifier loci are required
for the expression of the CCHS phenotype.
The identification of mutations in the RET-GDNF
pathway and the endothelin pathway in Ondine’s curse
sheds light on the genetic bases of this life-threatening
condition and further suggests that CCHS is a neural
crest cell disorder. Nevertheless, mutations have been
reported in a minority of patients tested thus far (Bolk
et al. 1996a). Finally, the involvement of at least three
genes belonging to distinct signaling pathways, the in-
complete penetrance of the mutation in carrier parents,
and the variable expression of the respiratory control
defect observed in the Ret / homozygous mice ex-
posed to hypercapnia (Burton et al. 1997) support the
view that an interactive polygenic inheritance is involved
in Ondine’s curse.
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